Journal of Gastroenterology

, Volume 44, Issue 3, pp 167–172 | Cite as

Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease

  • Sei Kakinuma
  • Hiromitsu Nakauchi
  • Mamoru Watanabe
Review

Abstract

Allogeneic liver transplantation is still the only effective treatment available to patients with liver failure. However, because there is a serious shortage of liver donors, an alternative therapeutic approach is needed. Transplantation of mature hepatocytes has been evaluated in clinical trials, but the long-term efficacy remains unclear and the paucity of donor cells limits this strategy. Stem-cell transplantation is a more promising alternative approach. Several studies have provided information about the mechanism underlying the proliferation and differentiation of hepatic stem/progenitor cells. Moreover, in experimental models of liver disease, transplantation of hepatic stem/progenitor cells or hepatocyte-like cells derived from multipotent stem cells led to donor cell-mediated repopulation of the liver and improved survival rates. However, before stem-cell transplantation can be applied in the clinic to treat liver failure in humans, it will be necessary to overcome several difficulties associated with the technique.

Key words

hepatocyte transplantation hierarchy single-cell based analysis 

References

  1. 1.
    Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105–111.PubMedCrossRefGoogle Scholar
  2. 2.
    Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663–676.PubMedCrossRefGoogle Scholar
  3. 3.
    Wagner W, Ho AD. Mesenchymal stem cell preparations—comparing apples and oranges. Stem Cell Rev 2007;3:239–248.PubMedCrossRefGoogle Scholar
  4. 4.
    Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41–49.PubMedCrossRefGoogle Scholar
  5. 5.
    Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103:1669–1675.PubMedCrossRefGoogle Scholar
  6. 6.
    Ema H, Nakauchi H. Self-renewal and lineage restriction of hematopoietic stem cells. Curr Opin Genet Dev 2003;13:508–512.PubMedCrossRefGoogle Scholar
  7. 7.
    Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996;273:242–245.PubMedCrossRefGoogle Scholar
  8. 8.
    Yamazaki S, Iwama A, Takayanagi S, Morita Y, Eto K, Ema H, et al. Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J 2006;25:3515–3523.PubMedCrossRefGoogle Scholar
  9. 9.
    Cheshier SH, Morrison SJ, Liao X, Weissman IL. In vivo proliferation and cell cycle kinetics of long-term self-renewing he matopoietic stem cells. Proc Natl Acad Sci U S A 1999;96:3120–3125.PubMedCrossRefGoogle Scholar
  10. 10.
    Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 1994;367:645–648.PubMedCrossRefGoogle Scholar
  11. 11.
    Shiojiri N, Lemire JM, Fausto N. Cell lineages and oval cell progenitors in rat liver development. Cancer Res 1991;51:2611–2620.PubMedGoogle Scholar
  12. 12.
    Suzuki A, Zheng YW, Kaneko S, Onodera M, Fukao K, Nakauchi H, et al. Clonal identification and characterization of selfrenewing pluripotent stem cells in the developing liver. J Cell Biol 2002;156:173–184.PubMedCrossRefGoogle Scholar
  13. 13.
    Tanimizu N, Nishikawa M, Saito H, Tsujimura T, Miyajima A. Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J Cell Sci 2003;116:1775–1786.PubMedCrossRefGoogle Scholar
  14. 14.
    Nitou M, Sugiyama Y, Ishikawa K, Shiojiri N. Purification of fetal mouse hepatoblasts by magnetic beads coated with monoclonal anti-e-cadherin antibodies and their in vitro culture. Exp Cell Res 2002;279:330–343.PubMedCrossRefGoogle Scholar
  15. 15.
    Watanabe T, Nakagawa K, Ohata S, Kitagawa D, Nishitai G, Seo J, et al. SEK1/MKK4-mediated SAPK/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis. Dev Biol 2002;250:332–347.PubMedGoogle Scholar
  16. 16.
    Oertel M, Menthena A, Chen YQ, Teisner B, Jensen CH, Shafritz DA. Purification of fetal liver stem/progenitor cells containing all the repopulation potential for normal adult rat liver. Gastroenterology 2008;134:823–832.PubMedGoogle Scholar
  17. 17.
    Kamiya A, Kakinuma S, Onodera M, Miyajima A, Nakauchi H. Prospero-related homeobox 1 and liver receptor homolog 1 coordinately regulate long-term proliferation of murine fetal hepatoblasts. Hepatology 2008;48:252–264.PubMedCrossRefGoogle Scholar
  18. 18.
    Suzuki A, Iwama A, Miyashita H, Nakauchi H, Taniguchi H. Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells. Development 2003;130:2513–2524.PubMedCrossRefGoogle Scholar
  19. 19.
    Suzuki A, Sekiya S, Buscher D, Izpisua Belmonte JC, Taniguchi H. Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression. Development 2008;135:1589–1595.PubMedCrossRefGoogle Scholar
  20. 20.
    Solt DB, Medline A, Farber E. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am J Pathol 1977;88:595–618.PubMedGoogle Scholar
  21. 21.
    Wang X, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Grompe M. The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A 2003;100Suppl 1:11881–11888.PubMedCrossRefGoogle Scholar
  22. 22.
    Oertel M, Shafritz DA. Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 2008;1782:61–74.PubMedGoogle Scholar
  23. 23.
    Fujio K, Evarts RP, Hu Z, Marsden ER, Thorgeirsson SS. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Lab Invest 1994;70:511–516.PubMedGoogle Scholar
  24. 24.
    Omori N, Omori M, Evarts RP, Teramoto T, Miller MJ, Hoang TN, et al. Partial cloning of rat CD34 cDNA and expression during stem cell-dependent liver regeneration in the adult rat. Hepatology 1997;26:720–727.PubMedCrossRefGoogle Scholar
  25. 25.
    Omori N, Evarts RP, Omori M, Hu Z, Marsden ER, Thorgeirsson SS. Expression of leukemia inhibitory factor and its receptor during liver regeneration in the adult rat. Lab Invest 1996;75:15–24.PubMedGoogle Scholar
  26. 26.
    Azuma H, Hirose T, Fujii H, Oe S, Yasuchika K, Fujikawa T, et al. Enrichment of hepatic progenitor cells from adult mouse liver. Hepatology 2003;37:1385–1394.PubMedCrossRefGoogle Scholar
  27. 27.
    Yamamoto H, Togo S, Zheng YW, Kubota T, Taniguchi H, Shimada H. Adult rat hepatic bipotent progenitor cells remain dormant even after extensive hepatectomy. Wound Repair Regen 2007;15:422–429.PubMedCrossRefGoogle Scholar
  28. 28.
    Schmelzer E, Reid LM. EpCAM expression in normal, nonpathological tissues. Front Biosci 2008;13:3096–3100.PubMedCrossRefGoogle Scholar
  29. 29.
    Makowka L, Rotstein LE, Falk RE, Falk JA, Nossal NA, Langer B, et al. Allogeneic and xenogeneic hepatocyte transplantation in experimental hepatic failure. Transplantation 1980;30:429–435.PubMedCrossRefGoogle Scholar
  30. 30.
    Rajvanshi P, Kerr A, Bhargava KK, Burk RD, Gupta S. Studies of liver repopulation using the dipeptidyl peptidase IV-deficient rat and other rodent recipients: cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule. Hepatology 1996;23:482–496.PubMedCrossRefGoogle Scholar
  31. 31.
    Gagandeep S, Rajvanshi P, Sokhi RP, Slehria S, Palestro CJ, Bhargava KK, et al. Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis. J Pathol 2000;191:78–85.PubMedCrossRefGoogle Scholar
  32. 32.
    Kobayashi N, Fujiwara T, Westerman KA, Inoue Y, Sakaguchi M, Noguchi H, et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000;287:1258–1262.PubMedCrossRefGoogle Scholar
  33. 33.
    Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998;338:1422–1426.PubMedCrossRefGoogle Scholar
  34. 34.
    Dhawan A, Mitry RR, Hughes RD, Lehec S, Terry C, Bansal S, et al. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 2004;78:1812–1814.PubMedCrossRefGoogle Scholar
  35. 35.
    Hamazaki T, Iiboshi Y, Oka M, Papst PJ, Meacham AM, Zon LI, et al. Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS Lett 2001;497:15–19.PubMedCrossRefGoogle Scholar
  36. 36.
    Chinzei R, Tanaka Y, Shimizu-Saito K, Hara Y, Kakinuma S, Watanabe M, et al. Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes. Hepatology 2002;36:22–29.PubMedCrossRefGoogle Scholar
  37. 37.
    Kumashiro Y, Asahina K, Ozeki R, Shimizu-Saito K, Tanaka Y, Kida Y, et al. Enrichment of hepatocytes differentiated from mouse embryonic stem cells as a transplantable source. Transplantation 2005;79:550–557.PubMedCrossRefGoogle Scholar
  38. 38.
    Teratani T, Yamamoto H, Aoyagi K, Sasaki H, Asari A, Quinn G, et al. Direct hepatic fate specification from mouse embryonic stem cells. Hepatology 2005;41:836–846.PubMedCrossRefGoogle Scholar
  39. 39.
    Cai J, Zhao Y, Liu Y, Ye F, Song Z, Qin H, et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 2007;45:1229–1239.PubMedCrossRefGoogle Scholar
  40. 40.
    Anjos-Afonso F, Siapati EK, Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 2004;117:5655–5664.PubMedCrossRefGoogle Scholar
  41. 41.
    Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, et al. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol 2008 Jun 25 [Epub ahead of print].Google Scholar
  42. 42.
    van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008;47:1634–1643.PubMedCrossRefGoogle Scholar
  43. 43.
    Sandhu JS, Petkov PM, Dabeva MD, Shafritz DA. Stem cell properties and repopulation of the rat liver by fetal liver epithelial progenitor cells. Am J Pathol 2001;159:1323–1334.PubMedGoogle Scholar
  44. 44.
    Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861–872.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Sei Kakinuma
    • 1
    • 2
  • Hiromitsu Nakauchi
    • 1
    • 2
  • Mamoru Watanabe
    • 3
  1. 1.Division of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, The Institute of Medical ScienceUniversity of TokyoTokyoJapan
  2. 2.JST, ERATONakauchi Stem Cell and Organ Regeneration ProjectTokyoJapan
  3. 3.Department of Gastroenterology and HepatologyTokyo Medical and Dental UniversityTokyoJapan

Personalised recommendations